Andrew Feinberg is the Chairman and CEO of Netcracker Technology, an industry leader offering mission-critical digital transformation solutions to communications service providers worldwide. In this role, he has guided the company through its longest sustained period of consistent market share gains and double-digit revenue growth, leading to its successful acquisition by NEC in 2008.
Feinberg drives Netcracker’s strategy and interacts with customers and key stakeholders while setting the tone for the company's values, culture and brand. At Mobile World Congress 2023, the world's largest and most influential event for the connectivity ecosystem, Feinberg was a featured thought leader in a keynote presentation that highlighted Netcracker's innovative solutions that enable telecommunications operators to remain successful in the digital economy. Feinberg serves on Netcracker's Executive Committee and is a member of the Board of Directors.
In addition, Feinberg is the President and CEO of BostonGene Corporation, a biomedical software company powering healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce the overall cost of cancer care. Since founding the company in 2015, Feinberg has established BostonGene as a market leader by integrating molecular and immune science with biomedical software, artificial intelligence and machine learning to develop and deliver clinically applicable innovative solutions to fight against cancer. Feinberg's leadership has led BostonGene to partner with leading cancer centers around the world, collaborate with physicians and scientists on hundreds of research projects, secure more than 100 patents and publish more than 100 landmark publications demonstrating the clinical utility of BostonGene's deep molecular and immune profiling and analytics to assist in treatment selection for cancer patients.
He holds an MBA from the Wharton School of the University of Pennsylvania and a B.S. from Bentley University.